Top 10 Healthcare Services Deals 2010-2019
What a decade it’s been for health care! The Affordable Care Act, enacted in 2010, unleased a tidal wave of change on the U.S. healthcare landscape that continues today. Even on the services side, pharmaceuticals figured into several transactions, from acquiring pharmacy benefits managers and contract research organizations (the R&D angle) to wholesale and distribution. With only a few days left in the decade, here’s a chart of the top 10 healthcare services deals announced since January 1, 2010, ranked by disclosed price. Five of the top 10 deals were announced in the last three years, including CVS Health’s (NYSE: CVS) $78 billion shocker targeting Aetna,... Read More »
Health Care M&A Deals, Week Ending December 13, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price Acorn Health Behavior Therapy Specialists N/A Biotechnology Acquirer Target Price Sanofi Synthorx, Inc. $2,500,000,000 Merck & Co., Inc. ArQule, Inc. $2,700,000,000 eHealth Acquirer Target Price InSight Telepsychiatry... Read More »
Healthcare Investors’ Attention Was on Turkeys in November
Thanksgiving came very late in November this year, landing on the 28th. That cuts the December shopping season down to four weeks, but it extended the time frame for getting deals done. With a preliminary total of 126 transactions for the month, it doesn’t feel as if anyone was in a rush to close their transactions. November’s deal volume was 14% lower than the previous month, which now totals 146 transactions. Compared with the roaring 165 deals announced in November 2018, the monthly total is down by 24%. Yes, more deals will pop up on the radar, as they were last month. We started with a total of 136 then and discovered 10 more. That’s how it goes, but 10 more deals here won’t move the... Read More »2020 Outlook and Opportunities
Here’s a prediction: Healthcare M&A will remain strong in 2020, at least until the November presidential election. Unless a recession hits before then. All of the analysts, lawyers and investment bankers we’ve spoken to in recent months agree on that scenario. Everyone is seeing robust deal flow and/or pipelines but knows the uncertainties that are sure to play out through the Democratic presidential primaries and into the general election could adversely affect this market. Their predictions are based on what has become status quo in the financial world. Low inflation, low cost of capital and a lot of money sitting in private funds on the sidelines, just waiting to get into the game.... Read More »
Health Care M&A Deals, Week Ending December 6, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Baker Bros. Advisors LP Royalties on KSI-301 $225,000,000 Astellas Pharma Inc. Audentes Therapeutics, Inc. $3,000,000,000 eHealth Acquirer Target Price Oasis Group Niche Health N/A Waystar Recondo Technology N/A Dedalus Group Agfa-Gevaert’s... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
